You are here: Profiles / Jay D. Amsterdam (List of Publications)
Wednesday, 26.04.2017

Jay D. Amsterdam, MD

BIBLIOGRAPHY

Depression Research Unit

Department of Psychiatry

University of Pennsylvania School of Medicine

Philadelphia, PA 19104

 

Phone: 856-448-0780

Fx: 856-428-1392

E-mail: jamsterd(at)mail.med.upenn(dot)edu

 

Books:

 

  • Psychobiology of Affective Disorders. J. Mendels, J.D. Amsterdam (eds.). New York, S. Karger, 1980, pp. 1-220.
  • Pharmacotherapy of Depression: Applications for the Outpatient Practitioner. J. Amsterdam (ed.) New York, Marcel Dekker, Inc. 1990, pp 1-496.
  • Refractory Depression. J. Amsterdam (ed.). New York, Raven Press 1991, pp 1-241. (Translated into Spanish and polish).
  • Refractory Depression. Nolan, W., Zohar, J., Roose, S., Amsterdam, J.D. (eds.). Chichester, John Wiley & Sons, 1994, pp 1-256.

 

o   Treatment-resistant Depression. Hornig-Rohan, M., Amsterdam, J.D. (eds.). "Psychiatric Clinics of North America", Philadelphia, W.B. Saunders, 1996, 19:1-412.

 

  • Treatment Resistant Mood Disorders - Advances in Research and Treatment. Amsterdam, J.D., Hornig-Rohan, M., Nierenberg, A. (eds.), Cambridge & New York, Cambridge University Press, 2001, pp 1-516.

 

 

Invited Journal Editorship:

 

o   Monoamine Oxidase Inhibitors: The First and Next Generation. Psychiatric Annals 31:346-394, 2001.

 

o   Mood Disorders In Women. Psychiatric Annals 32:397-436, 2002

 

o   Mood Disorders In Women. Psychiatric Annals 32: 447-2492, 2002

 

 

Articles & Chapters:

 

1. Amsterdam, J.D., Dubin, W.:  Huntington's chorea and dimethylaminoethanol.  Journal of Clinical Psychiatry, 39:626-628, 1978.

 

2. Amsterdam, J.D., Brunswick, D., Mendels, J.:  High dose desipramine, plasma drug levels, and clinical response.  Journal of Clinical Psychiatry, 40:141-143, 1979.

 

3. Brunswick, D.J., Amsterdam, J.D., Mendels, J.: Prediction of steady-state plasma imipramine and desipramine levels from single dose 24-hour study.  Journal of Clinical Pharmacology & Therapeutics, 25:605-610, 1979.

 

4. Amsterdam, J.D., Mendels, J.: Treatment resistant tardive dyskinesia: A new therapeutic approach.  American Journal of Psychiatry, 136:1197-1198, 1979.

 

5. Amsterdam, J.D., Brunswick, D., Mendels, J.: Clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. American Journal of Psychiatry, 137:653-662, 1980.

 

6. Brunswick, D.J., Amsterdam, J.D., Sandler, K., Schless, A., Mendels, J.:  Prediction of steady state amitriptyline plasma levels from a single-dose 24-hour sample in depressed outpatients. Journal of Clinical Psychiatry, 41:337-340, 1980.

 

7. Amsterdam, J.D., Brunswick, D.J., Mendels, J.:  Reliability of commercially available tricyclic antidepressant levels. Journal of Clinical Psychiatry, 41:206-207, 1980.

 

8. Amsterdam, J.D., Winokur, A., Mendels, J., Snyder, P.:  Distinguishing depression subtyped by thyrotropin response to TRH test. Lancet, ii:904, 1979.

 

9. Amsterdam, J.D., Winokur, A., Mendels, J., Caroff, S.:  Effect of gonadotropin-releasing hormone in depressed mood. Lancet, ii:1138, 1979.

 

10. Caroff, S., Amsterdam, J.D., Mendels, J.: Depression: Clinical manifestations and differential diagnosis. Philadelphia Medicine, 76:10-11, 1980.

 

11. Amsterdam, J.D., Mendels, J.: Depression: New strategies in tricyclic antidepressant therapy. Philadelphia Medicine, 76:61-63, 1980.

 

12. Nutter, D., Amsterdam, J.D., Mendels, J.: The clinical use of lithium carbonate. Philadelphia Medicine, 76:108-109, 1980.

 

13. Amsterdam, J.D., Mendels, J.: "Serotonergic function and depression."  In: The Psychobiology of Affective Disorders, (Mendels, J., Amsterdam, J.D., Eds.). New York, S. Karger, 1980, pages 57-71.

 

14. Amsterdam, J.D., Mendels, J.: "Summary of New Research Strategies in Affective Illness."  In The Psychobiology of Affective Disorders, (Mendels, J., Amsterdam, J.D., Eds.), New York, S. Karger, 1980, pages 201-208.

 

15. Amsterdam, J.D. Winokur, A., Caroff, S., Mendels, J.: Antidepressant effect of TRH in patients with primary depression, anorexia nervosa, and normal volunteers. American Journal of Psychiatry, 138:115-116, 1981.

 

16. Amsterdam, J.D., Winokur, A., Levin, R.: Sperm function in affective illness.  Psychosomatic Medicine, 43:183-185, 1981.

 

17. Amsterdam, J.D., Winokur, A., Caroff, S., Conn, J.: The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects. American Journal of Psychiatry, 139:284-291, 1982.

 

18. Amsterdam, J.D., Winokur, A., Caroff, S.: Dexamethasone suppression test as a prognostic tool. American Journal of Psychiatry, 137:979-980, 1981.

 

19. Amsterdam, J., Brunswick, D.: Vacutainer tubes and inconsistent values.  American Journal of Psychiatry, 138:390-391, 1981.

 

20. Amsterdam, J.D., Winokur, A., Caroff, S., Levin, R.: The effects of desmethylimipramine and lithium on human sperm function. Psychoneuroendocrinology, 6:359-363, 1981.

 

21. Amsterdam, J.D., Winokur, A., Caroff, S.: Effect of tricyclic antidepressants on the dexamethasone suppression test. American Journal of Psychiatry, 138:1245-1246, 1981.

 

22. Winokur, A., Amsterdam, J.D., Caroff, S., Snyder, P., Brunswick, D.: Variability of hormonal responses to a series of neuroendocrine challenges (TRH, GnRH, ITT, DST) in depressed patients. American Journal of Psychiatry, 139:39-44, 1982.

 

23. Amsterdam, J.D., Winokur, A., Caroff, S., Snyder, P.: Gonadotropin release after administration of GnRH in depressed patients and healthy volunteers. Journal of Affective Disorders, 3:367-380, 1981.

 

24. Caroff, S., Koenig, R., Winokur, A., Amsterdam, J., Puglia, C.: Acute metabolic response to cold exposure unipolar and bipolar II patients. Biological Psychiatry, 16:919-929, 1981.

 

25. Levin, R., Amsterdam,J.D., Winokur, A., Wein, A.J.:  Effects of psychotropic drugs on human sperm motility. Fertility and Sterility, 36:503-506, 1981.

 

26. Caroff, S., Winokur, A., Amsterdam, J.D., Snyder, P.: Diurnal variation of growth hormone secretion following thyrotropin-releasing hormone in normal men.  Psychosomatic Medicine, 46:59-66, 1984.

    

27. Amsterdam, J., Caroff, S., Potter, L., Brunswick, D., Conn, J., Rickels, K.: Double-blind comparison of doxepin and desipramine in patients with primary affective disorder. Acta Psychiatrica Scandinavica, 65:292-300, 1982.

 

28. Winokur, A., Amsterdam, J., Mihailovic, V., Caroff, S.: Improvement in ratings of tension after TRH administration in healthy women.  Psychoneuroendocrinology, 7:239-244, 1982.

 

29. Amsterdam, J.D., Winokur, A., Lucki, I., Snyder, P., Harris, S., Caroff, S., Rickels, K.: Growth hormone, prolactin, and thyrotropin responses to gonadotropin-releasing hormone in depressed patients and healthy volunteers. Psychoneuroendocrinology, 7:177-184, 1982.

 

30. Amsterdam, J.D.,Winokur, A., Lucki, I., Snyder, P.: Neuroendocrine regulation in depressed postmenopausal women and healthy subjects. Acta Psychiatrica Scandinavica, 67:43-49, 1983.

 

31. Amsterdam, J.D., Brunswick, D.J., Potter, L., Kaplan, M.: Cimetidine-induced alterations in desipramine plasma concentrations. Psychopharmacology, 83: 373-375,1984.

 

32. Winokur, A., Amsterdam, J.D., Oler, J., Mendels, J., Snyder, P.J., Caroff, S., Brunswick, D.J.: Multiple hormonal responses to TRH administration in depressed patients and healthy volunteers. Archives of General Psychiatry, 40:525-531, 1983.

 

33. Amsterdam, J.D., Winokur, A., Bryant, S., Larkin, J., Rickels, K.: The dexamethasone suppression test as a predictor of antidepressant response. Psychopharmacology, 80:43-45, 1983.

 

34. Amsterdam, J.D.,Winokur, A., Abelman, E., Lucki, I., Rickels, K.: Cosyntropin (ACTH-alpha-1-24) stimulation test in depressed patients and healthy subjects. American Journal of Psychiatry, 140:907-909, 1983.

 

35. Amsterdam, J.D., Winokur, A., Lucki, I., Caroff, S., Snyder, P., Rickels, K.: A neuroendocrine test battery in bipolar patients and healthy controls. Archives of General Psychiatry, 40:515-521, 1983.

 

36. Amsterdam, J.D., Winokur, A., Lucki, I., Snyder, P.: Pituitary hormone responses after infusion of gonadotropin-releasing hormone and saline in healthy men and women.  Psychoneuroendocrinology, 8:351-353, 1983.

 

37. Brunswick, D.J., Amsterdam, J.D., Potter, L., Caroff, S., Rickels, K.: Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine and doxepin. Acta Psychiatrica Scandinavica, 67:371-377, 1983.

 

38. Caroff, S.,Winokur, A.,Rieger,W., Schweizer, E., Amsterdam, J.D.: Response to dexamethasone in psychotic depression. Psychiatry Research, 8:59-64, 1983.

 

39. Winokur, A., Caroff, S., Amsterdam, J.D., Maislin, G.: Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response. Biological Psychiatry, 19:695-702, 1984.

 

40. Amsterdam, J.D., Lucki, I., Winokur, A.: The ACTH stimulation test in depression.  Psychiatric Medicine, 3:91-100, 1985.

 

41. Amsterdam, J.D., Jorkasky, D., Potter, L., and Cox, M.: A prospective study of lithium-induced nephropathy: preliminary results. Psychopharmacology Bulletin,          21:81-84, 1985.

 

42. Amsterdam, J.D., Brunswick, D.J., Potter, L., Winokur, A., Rickels, K.: Desipramine and 2-hydroxy desipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response. Archives of General Psychiatry, 42:361-364, 1985.

 

43. Schweizer, E., Amsterdam, J.D., Rickels, K.: Severe erythema multiform associated with zimelidine – a case report. Current Therapeutic Research, 37:124-126, 1985.

 

44.  Amsterdam, J.D., Winokur, A., Dyson, W., Gonzalez, F., Rott, R. and Koprowski, H.: “Demonstration of antibodies to borna virus in patients with affective disorders.”  In: Viruses, Immunity, and Mental Diseases, E. Kurstak (ed.), Plenum, New York; 1987, 179-188.

 

45. Rickels, K., Smith, W.T., Glaudin, V., Amsterdam, J.D., Weise, C., Settle, G.P.: Comparison of two dosage regimens of fluoxetine in major depression. Journal of Clinical Psychiatry, 46 [Sec. 2]: 38-41, 1985.

 

46. Brown, R., Kocsis, J.H., Caroff, S., Amsterdam, J.D., Winokur, A., Stokes, P., Frazer, A.: Differences in nocturnal melatonin secretion between melancholic depressed patients and controls. American Journal of Psychiatry, 142:811-816, 1985.

 

47. Rott, R., Herzog, S., Fleischer, B., Winokur, A., Amsterdam, J., Dyson, W., Koprowski, H.: Detection of serum antibodies to borna virus in patients with psychiatric disorders. Science, 228:755-756, 1985.

 

48. Amsterdam, J., Winokur, A., Dyson, W., Herzog, S., Gonzalez, F., Rott, R., Koprowski, H.: Borna disease virus: a possible etiology for affective disorder in humans?         Archives of General Psychiatry, 42:1093-1096, 1985.

 

49. Amsterdam, J.D., Rickels, K., Case, W.G., Csanalosi, I., Singer, M.: Double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression. Pharmacopsychiatry, 19:115-119, 1986. 

 

50. Schweizer, E., Amsterdam, J., Rickels, K., Kaplan, M., Droba, M.: Open trial of buspirone in the treatment of major depressive disorder. Psychopharmacology Bulletin, 22:183-185, 1986.

 

51. Amsterdam, J.D., Kaplan, M., Potter, L., Bloom, L., Rickels, K.: Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder. Psychopharmacology, 88:484-488, 1986.

 

52. Amsterdam, J.D., Schweizer, E., Winokur, A.: Multiple hormonal responses to insulin hypoglycemia in depressed patients and healthy volunteers. American Journal of Psychiatry, 144:170-175, 1987.

 

53. Amsterdam, J.D., Brunswick, D.J., Potter, L., Rickels, K.: Possible nonlinear pharmacokinetics of desipramine after once daily dosing. Pharmacopsychiatry, 19:84-87, 1986.

 

54. Winokur, A., Lindberg, N.D., Lucki, I., Phillips, J., Amsterdam, J.D.: Hormonal and behavioral effects associated with intravenous L-tryptophan administration.  Psychopharmacology, 88:213-219, 1986.  

 

55. Frazer, A., Brown, R., Kocsis, J., Caroff, S., Amsterdam, J.D., Winokur, A., Sweeney, J., Stokes, P.: Patterns of melatonin rhythms in depression. Journal of Neural Transmission (Suppl.), 21:269-290, 1986.

 

56. Amsterdam, J.D., Kaplan, M., Potter, L., Rickels, K.: Double-blind placebo-controlled study of cilobamine in major depression - lack of therapeutic efficacy. Current Therapeutic Research, 39:87-92, 1986.      

 

57. Amsterdam, J.D.: Loeffler's syndrome - an uncommon adverse reaction to imipramine. International Clinical Psychopharmacology, 1:260-262, 1986.

 

58. Amsterdam, J.D., Henle, W., Winokur, A., Wolkowitz, O., Pickar, D., Paul, S.M.: Serum antibodies to Epstein-Barr virus in patients with major depressive disorder.        American Journal of Psychiatry, 143:1593-1596, 1986.

 

59. Amsterdam, J.D., Marinelli, D.L., Arger, P., Winokur, A.: Assessment of adrenal gland volume by computer-assisted tomography in depressed patients and healthy volunteers. Psychiatry Research, 21:189-197, 1987.

 

60. Amsterdam, J.D., Maislin, G., Droba, M., Winokur, A.: The ACTH stimulation test before and after clinical recovery from depression. Psychiatry Research, 20:325-336, 1987.

 

61. Amsterdam, J.D., Berwish, N.: Treatment of refractory depression with combination reserpine and tricyclic antidepressant. Journal of Clinical Psychopharmacology, 7:238-242, 1987.

 

62. Rickels, K., Amsterdam, J.D., Avallone, M.F.: Fluoxetine in major depression: a controlled study. Current Therapeutic Research, 39: 559-563, 1986.

 

63. Amsterdam, J.D., Maislin, G., Abelman, E., Berwish, N., Winokur, A.: Adrenocortical responsiveness to the ACTH stimulation test in depressed patients and healthy volunteers. Journal of Affective Disorders, 11: 265-274,1986.

 

64. Amsterdam, J.D., Berwish, N., Potter, L., Rickels, K.: Open trial of gepirone in the treatment of major depressive disorder. Current Therapeutic Research, 41:185-193, 1987.

 

65. Amsterdam, J.D., Settle, R.G., Doty, R.L., Abelman, E., Winokur, A.: Taste and smell perception in depression. Biological Psychiatry, 22: 1481-1484, 1987.

 

66. Rickels, K., Chung, H.R., Csanalosi, I.B., Hurowitz, A.M., London, J., Wiseman, K., Kaplan, M.J., Amsterdam, J.D.: Alprazolam, diazepam, imipramine and placebo in major depressive disorder. Archives of General Psychiatry, 44:862-866, 1987.

 

67. Jorkasky, D.K., Amsterdam, J.D., Oler, J., Braden, G., Alvis, R., Gehab, M., Cox, M.: Lithium-induced renal disease: a prospective study. Clinical Nephrology, 30:293-302, 1988.

 

68. Winokur, A., Maislin, G., Amsterdam, J.D.: Insulin resistance after oral glucose tolerance testing in patients with major depression. American Journal of Psychiatry, 145:325-330, 1988.

 

69. Amsterdam, J.D., Maislin, G., Winokur, A., Gold, P.: Pituitary and adrenocortical responses to ovine corticotropin-releasing hormone in depressed patients and healthy volunteers. Archives of General Psychiatry, 44:775-781, 1987.

 

70. Amsterdam, J.D., Rybakowski, J., Gottlieb, J., Frazer, A.: Kinetics of erythrocyte lithium-sodium counter transport in patients with affective illness before and during lithium treatment. Journal of Affective Disorders,14:75-82, 1988.

 

71. Amsterdam, J.D., Maislin, G., Winokur, A., Berwish, N., Kling, M., Gold, P.W.:  The oCRH stimulation test before and after clinical recovery from depression. Journal of Affective Disorders, 14:213-222, 1988.

 

72. Amsterdam, J.D., Maislin, G., Skolnick, B, Berwish N, Winokur, A.: Multiple hormonal responses to clonidine administration in depressed patients and healthy volunteers. Biological Psychiatry, 26:265-278, 1989.

 

73. Berwish, N., Amsterdam, J.D.: An overview of investigational antidepressants. Psychosomatics, 30:1-18, 1989.

 

74. Brown, R.P., Kocsis, J.H., Caroff, S., Amsterdam, J.D., Winokur, A., Stokes, P., Frazer, A.: Depressed mood and reality disturbances correlate with decreased nocturnal melatonin in depressed patients. Acta Psychiatrica Scandinavica, 76:272-281, 1987.

 

75. Amsterdam, J.D., Berwish, N.: High dose tranylcypromine treatment in refractory depression. Pharmacopsychiatry, 22:21-25, 1989.

 

76. Amsterdam, J.D, Maislin, G., Berwish, N., Phillips, J., Winokur, A.: Enhanced adrenocortical sensitivity to submaximal doses of cosyntropin (ACTH) in depressed patients. Archives of General Psychiatry, 46:550-558, 1989.

 

77. Rybakowski, J.K., Dyson, W.L., Amsterdam, J.D.: Alexithymia and somatic conditions in patients with affective illnesses during lithium prophylaxis. Psychotherapy and Psychosomatics, 49:1-5, 1988.

 

78. Amsterdam, J.D., Dunner, D.L., Fabre, L.F., Kiev, A., Rush, A.J., Goodman L.I.: Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression. Pharmacopsychiatry, 22:137-143, 1989.

 

79. Amsterdam, J.D., Maislin, G., Winokur, A., Phillips, J., Berwish, N., Gold, P.: Assessment of abnormalities in hormonal responsiveness at multiple levels of the hypothalamic-pituitary-adrenocortical axis in depressive illness. Psychoneuroendocrinology, 14:43-62, 1989.

 

80. Bode, L., Riegel, S., Ludwig, H., Amsterdam, J.D., Lange, W., Koprowski, H.: Borna disease virus-specific antibodies in patients with HIV infections and with mental disorders. Lancet, ii: 689, 1988.    

 

81. Rybakowski, J., Amsterdam, J.D., Dyson, W.L., Frazer, A., Winokur, A., Kurtz, J.: Factors contributing to erythrocyte lithium-sodium countertransport activity in lithium-treated bipolar patients. Pharmacopsychiatry, 22:16-20, 1989.

 

82. Rickels, K., Amsterdam, J.D., Clary, C., Fox, I., Schweizer, E., Weise, C.: A placebo-controlled, double-blind clinical trial of paroxetine in depressed outpatients. Acta        Psychiatrica Scandinavica, 80 (Suppl. 350):117-123, 1989.

 

83. Schweizer, E., Rickels, K., Amsterdam, J.D., Fox, I., Puzzuoli, G., Weise, C.: What constitutes an adequate antidepressant trial of fluoxetine? Journal of Clinical Psychiatry, 51:8-11, 1990.

 

84. Amsterdam, J.D., Maislin, G., Rybakowski, J.: A possible anti-viral action of lithium carbonate in herpes simplex virus infections. Biological Psychiatry, 27:447-453, 1990.

 

85. James, S.P., Amsterdam, J.D.: Sleep and affective disorders.  In: Amsterdam, J.D. (ed.). Pharmacotherapy of Depression: Application for the Outpatient Practitioner, Marcel        Dekker, Inc., New York 1990, pp 427-440.

 

86. Berwish, N., Amsterdam, J.D.: The nosology of affective disorders. In: Amsterdam, J.D. (ed.). Pharmacotherapy of Depression: Application for the Outpatient Practitioner, Marcel Dekker, Inc., New York 1990, pp 1-12.

 

87. Amsterdam, J.D., Maislin, G.: The suppression of herpes simplex virus infections with lithium carbonate. In: Kurstak, E. (ed.). Psychiatry and Biological Factors, Plenum, New York 1991, pp 257-268.

 

88. Amsterdam, J.D., Maislin, G., Potter, L., Giuntoli, R., Koprowski, H.: Suppression of recurrent genital herpes infections with lithium carbonate: A randomized, placebo-controlled study. Lithium, 2:17-25, 1991.

 

89. Amsterdam, J.D.: Use of high dose tranylcypromine in resistant depression. In: Amsterdam, J. (ed.) Refractory Depression, Raven Press, New York 1991, pp 123-130.

 

90. Rickels, K., Amsterdam, J., Clary, C., Hassman, J., London, J., Puzzoli, G., and Schweizer, E.: Buspirone in depressed outpatients: A controlled study. Psychopharmacology Bulletin, 26:163-167, 1990. 

 

91. Amsterdam, J.D., Maislin, G., Winokur, A.: A comparison of growth hormone response to clonidine and insulin hypoglycemia in depressed and healthy subjects. Biological Psychiatry, 28:308-314, 1990.

 

92. Zohar, J., Kaplan, Z., Amsterdam, J.D.: Reserpine addition in resistant depression - a review. In: Amsterdam, J. (ed.). Refractory Depression, Raven Press, New York 1991, pp 219-222.

 

93. Rybakowski, J., Amsterdam, J.D.: Lithium prophylaxis and recurrent labial herpes infections. Lithium, 2:43-47, 1991.

 

94. Nierenberg, A.A., Amsterdam J.D.: Resistant Depression: definition and treatment approaches. Journal of Clinical Psychiatry, 51 (Suppl. 6): 39-47, 1990

 

95. Amsterdam, J.D., Maislin, G., Potter, L., Guintoli, R.: Reduced rate of recurrent genital herpes infections with lithium. Psychopharmacology Bulletin, 26:339-343, 1990.

 

96. Settle, R.G., Amsterdam, J.D.: Depression and the chemical senses. In: Getchell, T.V., Doty, R.L., Bartoshuk, L.M., Snow, J.B. (eds.). Smell and Taste in Health and Disease, Raven Press, New York 1991, pp 851-862.

 

97. Amsterdam, J.D., Maislin, G.: Effect of erythromycin on tricyclic antidepressant metabolism. Journal of Clinical Psychopharmacology, 11:203-206, 1991.

 

98. Amsterdam, J.D., Maislin, G.: Hormonal responses during insulin-induced hypoglycemia in manic-depressed, unipolar depressed and healthy control subjects. Journal of Clinical Endocrinology and Metabolism, 73:541-548, 1991.

 

99. James, S.P., Potter, L., Berwish, N., Amsterdam, J.D.: Polysomnography in refractory depression. In: Amsterdam, J. (ed.). Refractory Depression, Raven Press, New York 1991, pp 81-86.

 

100. Rickels, K., Amsterdam, J.D., Clary, C., Puzzuoli, G., Schweizer, E.: Buspirone in major depression: a controlled study. Journal of Clinical Psychiatry, 52:34-38, 1991.

 

101. Amsterdam, J.D., Mozley, P.D.: Temporal lobe asymmetry with iofetamine (IMP) SPECT imaging in patients with major depression. Journal of Affective Disorders, 24:43-53, 1992.

 

102. Amsterdam, J.D.: Gepirone, a selective serotonin (5-HT1A) partial agonist in the treatment of major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 16:271-280, 1992.

 

103. Rickels, K., Amsterdam, J.D., Clary, S., Fox, I., Schweizer, E., Weise, C.: The efficacy and safety of paroxetine compared with placebo in outpatients with major depression. Journal of Clinical Psychiatry, 53 (Suppl. 2):30-32, 1992.

 

104. Rosenzweig, M.H., Amsterdam, J.D.: Treatment resistant depression: additional perspectives. Journal of Pharmacology, 6:167-171, 1992.

 

105. Fu, Z.F., Amsterdam, J.D., Kao, M., Shankar, V., Koprowski, H., Dietzschold, B.: Detection of Borna disease virus-specific antibodies from patients with affective disorders by western immunoblot technique. Journal of Affective Disorders, 27:61-68, 1993.

 

106. Amsterdam, J.D., Hernz, W.H.: Serum antibodies to herpes simplex virus types I and II in depressed patients and healthy controls. Biological Psychiatry, 34:417-420, 1993.

 

107. Lish, J.D., Gyulai, L., Resnick, S.M., Kirtland, A., Amsterdam, J.D., Whybrow, P.C., and Price, A.: A family history study of rapid-cycling bipolar disorder.  Psychiatry Research, 48:37-45, 1993.

 

108. Rybakowski, J.K., Amsterdam, J.D., Prystowsky, M.B.: Blood cell indices in affective patients during lithium prophylaxis. Lithium, 4:205-209, 1993.

 

109. Amsterdam, J.D., Maislin, G.: Fluoxetine efficacy in treatment resistant depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 18:243-261, 1994.

 

110. Hornig-Rohan, M., Amsterdam, J.D.: Clinical and biological correlates of treatment-resistant depression: an overview. Psychiatric Annals, 24:220-227, 1994.

 

111. Fava, M., Rosenbaum, J.F., McGrath, P.J., Stewart, J.W., Amsterdam, J.D., Quitkin, F.M.: Lithium and tricyclic augmentation of fluoxetine treatment for resistant depression: A double-blind, controlled study. American Journal of Psychiatry, 151:1372-1374, 1994.

 

112. Amsterdam, J.D., Mozley, P.D., Rosenzweig, M.: Assessment of adrenocortical activity in refractory depression: steroid suppression with ketoconazole. In: Nolan, W., Zohar, J., Roose, S., Amsterdam, J.D. (eds.) Refractory Depression, John Wiley & Sons, Chichester, 1994, pp.199-210.

 

113. Amsterdam, J.D., Hornig-Rohan, M.: Efficacy of alprazolam in reducing fluoxetine-induced "jitteriness" in patients with major depression. Journal of Clinical Psychiatry, 55:394-400, 1994.

 

114. Amsterdam, J.D., Maislin, G., Rosenzweig, M., Halbrecht, U.: Gonadotropin (LH and FSH) response after submaximal GnRH stimulation in depressed patients and healthy controls. Psychoneuroendocrinology, 20:311-321, 1995.

 

115. Mozley, P.D., Hornig-Rohan, M., Woda, M., Kim, H.J., Payer, F., Amsterdam, J.D.: Relative activity of Tc-99m HMPAO in brain regions that have been implicated in the pathophysiology of depression. Progress in Neuro-Psycho-pharmacology & Biological Psychiatry, 20:443-458, 1996.

 

116. Amsterdam, J.D., Mozley, P.D., Hornig-Rohan: Normalization of asymmetric temporal lobe IMP activity in treatment-resistant depression. Depression, 3:273-277, 1996.

 

117. Amsterdam, J.D., Maislin, G., Hooper, M.B.: Suppression of herpes simplex virus infection with oral lithium carbonate - a possible antiviral activity, Pharmacotherapy, 16: 1070-1075, 1996.

 

118. Sramek, J.J., Tansman, M., Suri, A., Hornig-Rohan, M., Amsterdam, J.D., Stahl, S., Weisler, R.H., Cutler, N.R.: Efficacy of buspirone in generalized anxiety disorder with coexisting depressive symptoms. Journal of Clinical Psychiatry, 57:287-291, 1996.

 

119. Amsterdam, J.D., Hornig-Rohan, M.: Treatment algorithms in treatment-resistant depression. In: Hornig-Rohan, M. & Amsterdam, J.D. (eds.). "Treatment-resistant Depression," Psychiatric Clinics of North America, 19:371-386, 1996.

 

120. Hornig-Rohan, M., Wolkowitz, O., Amsterdam, J.D.: Novel pharmacologic approaches to treatment-resistant depression. In: Hornig-Rohan, M. & Amsterdam, J.D. (eds.).  "Treatment-resistant Depression," Psychiatric Clinics of North America, 19:387-405, 1996.

 

121. Hornig-Rohan, M., Amsterdam, J.D.: Prolactin, growth hormone, insulin, glucagons, and parathyroid hormone: Psychobiological & Clinical Implications. In: Wolkowitz, O.M. & Rothschild, A. (eds.). Psychoneuroendocinology for the Clinician, American Psychiatric Press, Inc., Washington, D.C., 2002, pp 107-138.

 

122. Amsterdam, J.D., Fava, M., Maislin, G., Rosenbaum, J., Hornig-Rohan, M.: TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. Journal of Affective Disorders, 38:165-172, 1996.

 

123. Hornig-Rohan, M., Mozley, P.D., Amsterdam, J.D.: HMPAO SPECT brain imaging in patients with treatment-resistant depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 21:1097-1114, 1997.

 

124. Ricketts, M.H., Amsterdam, J.D., Park, D., Yang, R-S., Poretz, R.D., Zhang, X., Fanale, M., Badoo, A., Manowitz, P.: A novel Arylsulfatase A protein variant and genotype in two patients with major depression. Journal of Affective Disorders, 40:137-147, 1996.

 

125. Amsterdam, J.D., Fawcett, J., Quitkin, F.M., Reimherr, F.W., Rosenbaum, J., Michelson, D., Hornig-Rohan, M., Beasley, C.: Fluoxetine and norfluoxetine plasma levels in major depression: A multi-center study. American Journal of Psychiatry, 154:963-969, 1997.

 

126. Amsterdam, J.D., Garcia-Espana, F., Rosenzweig, M.: Clomipramine augmentation in refractory depression.  Depression, 5:84-90, 1997.

 

127. Szuba, M.P., Amsterdam, J.D.: Rapid conversion from one MAO inhibitor to another. Journal of Clinical Psychiatry, 58:307-310, 1997.

 

128. Amsterdam, J.D., Garcia-Espana, F., Goodman, D., Hooper, M., Hornig-Rohan, M.: Breast enlargement during chronic SSRI therapy Journal of Affective Disorders, 46:151-156, 1997.

 

129. Amsterdam, J.D., Hooper, M.: Bone density measurements in major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 22:267-277, 1998.

 

130. Stewart, J.W., Quitkin, F.M., McGrath, P.J., Amsterdam, J.D., Fava, M., Fawcett, J., Reimherr, F., Rosenbaum, J., Roback, P. Pattern analysis predicts differential relapse on fluoxetine and placebo following acute treatment. Archives of General Psychiatry, 55:334-343, 1998.

 

131. Hornig-Rohan, M., Goodman, D., Camoun, A., Amsterdam, J.D.: Positive and negative acute phase proteins in affective subtypes. Journal of Affective Disorders, 49:9-18, 1998.

 

132. Amsterdam, J.D., Garcia-Espana, F.: Rates of flu-like infections in patients with affective illness. Journal of Affective Disorders, 47:177-182, 1998.

 

133. Amsterdam, J.D., Hooper, M., Amchin, J.: Efficacy and safety of once vs. twice daily venlafaxine in patients with major depression. Journal of Clinical Psychiatry, 59:236-240, 1998.

 

134. Zajecka, J., Fawcett, J., Amsterdam, J.D., Quitkin, F., Reimherr, F., Rosenbaum, J., Michelson, D., Beasley, C.: Safety of abrupt discontinuation of fluoxetine: A randomized, placebo-controlled study. Journal of Clinical Psychopharmacology, 18:193-197, 1998.

 

135. Amsterdam, J.: Efficacy and safety of venlafaxine in bipolar type-II and unipolar major depressive disorder. Journal of Clinical Psychopharmacology, 18:414-417, 1998.

 

136. Amsterdam, J.D., Garcia-Espana, F., Schweizer, E., Fawcett, J., Quitkin F.M., Reimherr, F.W., Rosenbaum, J., Beasley, C.: Fluoxetine and bipolar II major depressive episode. Journal of Clinical Psychopharmacology, 18:435-440, 1998.

 

137. Amsterdam, J.D.: SSRI efficacy in severe and melancholic depression. Journal of Psychopharmacology, [Supp B]: S99-S111, 1998.

 

138. Amsterdam, J.D., Garcia-Espana, F., Fawcett, J., Quitkin F.M., Reimherr, F., Rosenbaum, J., Beasley, C.: Blood pressure changes during acute fluoxetine treatment. Journal of Clinical Psychopharmacology, 19:9-14, 1999.

 

139. O'Reardon, J., Amsterdam, J.D.: Mechanisms and management of treatment-resistant affective disorders. In: Montgomery, S, Halbreich (eds.). Pharmacotherapy of Mood and Cognition, Washington, D.C., American Psychiatric Press, pp. 295ff, 1999.

 

140. Reimherr, F.W., Amsterdam, J.D., Fawcett, J., Quitkin F.M., Rosenbaum, J., Beasley, C., Michelson, D., Roback, P., Sundell, K.: Optimal length of continuation therapy: a prospective assessment during fluoxetine long-term treatment. American Journal of Psychiatry, 55:1247-1253, 1998.

 

141. Hornig-Rohan, M., Amsterdam, J.D.: Venlafaxine versus stimulant therapy in patients with dual diagnoses of attention deficit disorder and depression. Progress in Neuro-        Psychopharmacology & Biological Psychiatry, 26:585-589, 2002.

 

142. O'Reardon, J., Amsterdam, J.D.: Treatment-resistant depression - promises and limitations. Psychiatric Annals, 28:633-630, 1998.

 

143. Amsterdam, J.D., Garcia-Espana, F., Fawcett, J., Quitkin, F.M., Reimherr, F., Rosenbaum, J., Beasley, C.: Fluoxetine efficacy in menopausal women with and without estrogen replacement. Journal of Affective Disorders, 55:11-17, 1999.

 

144. Hornig, M., Amsterdam, J.D., Camoun, A., Goodman, D.: Auto-antibodies in affective disorders. Journal of Affective Disorders, 55:29-37, 1999.

 

145. Michelson, D., Amsterdam, J.D., Fawcett, J., Quitkin, F., Reimherr, F., Rosenbaum, J., Sundell, K., Kim, Y., Beasley, C.: Changes in weight during a 1-year trial of fluoxetine in major depression. American Journal of Psychiatry, 156:1170-1176, 1999.

 

146. Moreno, J., Caplan, A.L., Wolpe, P.R., Amsterdam, J.D., and the Members of the Project on Informed consent, Human Research Ethics Group: Updating protections for human subjects involved in research. Journal of the American Medical Association, 280:1951-1958, 1998.

 

147. Fava, M., Amsterdam, J.D., Deltito, J.A., Salzman, C., Schwaller, M., Dunner, D.L.: A double-blind study of paroxetine, fluoxetine and placebo in outpatients with major depression. Annals of Clinical Psychiatry, 10:145-150, 1998.

 

148. O'Reardon, J., Amsterdam, J.D.: Overview of treatment-resistant depression and its management. In: Amsterdam, J.D., Nierenberg, A., Hornig, M. (eds.). Treatment Resistant Mood Disorders - Advances in Research and Treatment, Cambridge University Press, Cambridge (UK), 2001, pp. 30-45.

 

149. O'Reardon, J., Amsterdam, J.D.: Medical disorders and treatment-resistant depression. In: Amsterdam, J.D., Nierenberg, A., Hornig, M. (eds.). Treatment Resistant Mood Disorders - Advances in Research and Treatment, Cambridge University Press, Cambridge (UK), 2001, pp. 405-429.

 

150. Endicott, J., Amsterdam, J.D., Erickson, E., Frank, E., Freeman, E., Hisschfield, R., Ling, F., Parry, B., Pearlstein, T., Rosenbaum, J., Rubinow, D., Schmidt, P., Severono, S., Steiner, M., Stewart, D., Thys-Jacobs, S.: Is premenstrual dysphoric disorder (PMDD) a distinct clinical entity? Journal of Women's Health, 8:663-679, 1999.

 

151. Souery, D., Amsterdam, J.D., de Montigny, C., Lecrubier, Y., Montgomery, S., Lipp, O., Racagni, R., Zohar, J., Mendlewicz, J.: Treatment resistant depression: methodological overview and operational criteria. European Psychopharmacology, 9:83-91, 1999.

 

152. Michelson, D., Amsterdam, J.D., Apter, J., Fava, M., Londborg, P., Tamura, R., Pagh, L.: Activation of stress-responsive hormones associated with interruption of selective serotonin reuptake inhibitor treatment. Psychoneuroendocrinology, 25:169-177, 2000.

 

153. O’Reardon, J.P., Amsterdam, J.D., Brunswick, D.J.: Systematic approach to SSRI non-response. Current Opinions in Psychiatry, 13:93-98, 2000.

 

154. McGrath, P., Stewart, J., Petkova, E., Quitkin, F.M., Amsterdam, J.D., Fawcett, J., Reimherr, F.W., Rosenbaum, J., Beasley, C.: Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression. Journal of Clinical Psychiatry, 61:518-524, 2000.

 

155. Michelson, D., Amsterdam, J.D., Fava, M., Apter, J., Londborg, P.: Interruption of selective serotonin reuptake inhibitor treatment: a double-blind, placebo-controlled trial. British Journal of Psychiatry, 176:363-368, 2000.

 

156. Zajecka, J., Fawcett, J., Amsterdam, J.D., Quitkin, F., Reimherr, F., Rosenbaum, J., Fava, M., Tamura, R., Sundell, K., Michelson, D., Beasley, C.: Changes in adverse events in patients during six months of fluoxetine therapy, Journal of Clinical Psychiatry, 60:389-394, 1999.

 

157. Amsterdam, J.D., Garcia-Espana, F.: Venlafaxine monotherapy in women with bipolar II depression. Journal of Affective Disorders, 59:225-229, 2000.

 

158. Brunswick, D.J., Amsterdam, J.D., Fawcett, J., Quitkin, F.M., Reimherr, F.W., Rosenbaum, J.F., Beasley, C.M., Jr.: Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment. Journal of Affective Disorders, 68:243-249, 2002.

 

159. Nair, S.R.N., O’Reardon, J.P., Sethi, S.S., Amsterdam, J.D.: Gender and bipolar disorder: A mixed picture for women. Psychiatric Annals, 30:465-471, 2000

 

160. Sluzewka, A., Rybakowski, J., Amsterdam, J.D.: Immunologic factors in refractory depression. In: Amsterdam, J.D., Nierenberg, A., Hornig, M. (eds.) Treatment Resistant Mood Disorders - Advances in Research and Treatment, Cambridge University Press, Cambridge (UK), 2001, pp. 142-156.

 

161. Szuba, M.P., O’Reardon, J.P., Kastenberg, J., Gettes, D.R., Wassermen, E., Evans, D.L., Amsterdam, J.D.: Acute mood and TSH effects of transcranial magnetic stimulation in major depression. Biological Psychiatry, 50:22-27, 2001.

 

162. Brunswick, D.J., Amsterdam, J.D., Fawcett, J., Quitkin, F.M., Reimherr, F.W., Rosenbaum, J.F., Beasley, C.M., Jr.: Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy. Journal of Clinical Psychopharmacology, 21:616-618, 2001.

 

163. Rybakowski, J.K., Sluzewka, A., Amsterdam, J.D.: The effects of long-term treatment with lithium on immunological functions. In: Lucas, A.C., Becker, R.W., Gallicchio, V.S. (eds.) Lithium - 50 years: Recent Advances in Biology and Medicine. Cheshire (USA), Weidner Publishing, 1999, pp. 123-136.

 

164. Bodkin, A.J., Amsterdam, J.D.: A double-blind, placebo-controlled, parallel group study of transdermal selegiline (a selective monoamine oxidase B inhibitor) in out-patients with major depression. American Journal of Psychiatry, 159:1869-1875, 2002.

 

165. Amsterdam, J.D., Brunswic, D.J., O’Reardon, J.: Bipolar disorder in women. Psychiatric Annals, 32:397-404, 2002.

 

166. Amsterdam, J.D., Chopra, M.: Monoamine oxidase (MAO) inhibitors revisited. Psychiatric Annals, 31:361-370, 2001.

 

167. Mortola, J.F., Brunswick, D.J., Amsterdam, J.D.: Premenstrual syndrome: cyclic symptoms in women of reproductive age. Psychiatric Annals, 32:452-464, 2002.

 

168. Amsterdam, J.D., Brunswick, D.J.: Site variability in treatment outcome in antidepressant drug trials. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26:989-993, 2002.

 

169. Amsterdam, J.D. Brunswick, D.J.: Antidepressant monotherapy for bipolar type II major depression. Bipolar Disorders, 5:388-395, 2003.

 

170. Amsterdam, J.D., Shults, J., Brunswick, D.J., Hundert, M.: Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression – Low manic switch rate. Bipolar Disorders, 6:75-81, 2004.

 

171. Amsterdam, J.D., Brunswick, D.J., Hundert, M.: A Single-site, double-blind, placebo-controlled, dose ranging study of YKP10A - a putative, new antidepressant. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26:1333-1338, 2002.

 

172. Quitkin, F., Petkova, E., McGrath, P., Nunes, E., Taylor, B., Beasley, C., Stewert, J., Amsterdam, J.D., Fava, M., Reimherr, F., Fawcett, J., Klein, D.: When should a trial of fluoxetine for major depression be declared failed? American Journal of Psychiatry, 160:734-740, 2003.

 

173. Amsterdam, J.D.: A double-blind, placebo-controlled clinical trial of the safety and efficacy of the selegiline transdermal system without dietary restrictions in patients with major depression. Journal of Clinical Psychiatry, 64:208-214, 2003.

 

174. Amsterdam, J.D. Brunswick, D.J., Gibertini, M.: Sustained efficacy of gepirone-IR in major depressive disorder: A double-blind, placebo substitution trial. Journal of Psychiatric Research, 38:259-265, 2004.

 

175. Brunswick, D.J., Amsterdam, J.D., Mozley, P.D., Newberg, A.B.: Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.  American Journal of Psychiatry, 160:1836-1841, 2003. 

 

176. Brunswick, D.J., Goodman, D.B., O’Reardon, J.P., Chopra, M., Amsterdam, J.D.: Pindolol does not augment cortisol and prolactin response to paroxetine in healthy subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 28:477-480, 2004.

 

177. Reivich, M., Amsterdam, J.D., Brunswick, D.J., Shiue, C.Y.: [11C](+)McN5652 PET brain imaging may show increased serotonin transporter availability  in major depression Journal of Affective Disorders, 82:321-327, 2004.

 

178. Gerrity, T.R., Papanicolaou. D.A., Amsterdam, J.D., Bingham, S., Grossman, A., Hedrick, T., Herberman, R.B., Krueger, G., Levine, S., Mohagheghepour, N., Moore, R.C.,  Oleske, J., Snell, C.R.: Immunologic aspects of chronic fatigue syndrome. Neuroimmunomodulation, 11:351-357, 2004.

 

179. DeRubeis, R.J., Hollon, S.D., Amsterdam, J.D., Shelton, R.C., Young, P.R., Salomon, R.M., O’Reardon, J.P., Lovett, M.L., Gladis, M.M., Brown, L.L., Gallop, R.: Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62:409-416, 2005.

 

180. Hollon, S.D., DeRubeis, R.J., Shelton, R.C., Amsterdam, J.D., Salomon, R.M., O’Reardon, J.P., Lovett, M.L., Young, P.R., Haman, K.L., Freeman, B.B., Gallop, R.: Prevention of relapse following cognitive therapy versus medications in moderate to severe depression. Archives of General Psychiatry, 62:417-422, 2005.

 

181. Boyd, R.C., Amsterdam, J.D.: Mood disorders in women from adolescence to late life: An overview.  Clinical Obstetrics & Gynecology, 4:515-526, 2004.

 

182. Staab, J.P., Ruckenstein, M.J., Amsterdam, J.D.: A prospective trial of sertraline for chronic subjective dizziness. Laryngoscope, 114:1637-1641, 2004

 

183. Papanicolaou. D.A., Amsterdam, J.D., Levine, S., McCann, S.M., Moore, R.C., Newbrand, C.H., Allen G., Nisenbaum, R.,  Pfaff, D.W., Tsokos, G.C.: Neuroendocrine aspects of chronic fatigue syndrome. Neuroimmunomodulation, 11:65-74, 2004.

 

184. Amsterdam, J.D., Shults, J.: Fluoxetine monotherapy for bipolar type II and bipolar NOS major depression – A double-blind, placebo-substitution, continuation study. International Clinical Psychopharmacology, 20:357-364, 2005.

 

185. Amsterdam, J.D., Shults, J.: MAOI safety and efficacy in advanced treatment-resistant depression – A retrospective analysis. Journal of Affective Disorders, 89:183-188, 2005.

 

186. Amsterdam, J.D., Shults, J.: Comparison of fluoxetine, olanzapine, and fluoxetine plus olanzapine in bipolar type I and bipolar type II major depression – Lack of manic induction. Journal of Affective Disorders, 87:121-130, 2005.

 

187. Szuba, M.P., Amsterdam, J.D.: Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression. Journal of Clinical Psychopharmacology, 25:325-330, 2005.

 

188. Newberg, A.B., Amsterdam, J.D., Wintering, N., Ploessl, K., Swanson, R.L., Shults, J., Alavi, A.: 123I ADAM binding to serotonin transporters in patients with major epression and healthy controls: A preliminary study. Journal of Nuclear Medicine, 46:993-997, 2005.

 

189. Amsterdam, J.D.: Treatment-resistant depression – An overview. In: Planell, L.S. , Ruiloba, J.V., Menchon-Magrina, J.M., Quevedo, C.D. (eds.), Patologias Resistentes en Psiquiatria, Barcelona, Spain, ARS Medica, pp. 79-92, 2005.

 

190. Michelson, D., Adler, L.,  Amsterdam, J.D., Dunner, D.L., Nierenberg, A.A., Reimherr, F.W., Schatzberg, A.F., Kelsey, D.K., Williams, D.W.: Addition of atomoxetine for depression incompletely responsive to sertraline: A randomized, double blind, placebo controlled study. Journal of Clinical Psychiatry, 68:582–587, 2007.

 

191. Perlis, R.H., Beasley, C.M. Jr., Wines, J.D. Jr., Tamura, R.N., Cusin, C., Shear, D., Amsterdam, J.D., Quitkin, F.,  Strong, R.E., Rosenbaum, J.F., Fava, M.: Treatment-associated suicidal ideation and adverse effects in an open, multi-center trial of fluoxetine for major depressive episodes. Psychotherapy & Psychosomatics, 76:40-46, 2007.

192. Amsterdam, J.D., Rutherford, N., Shults, J.: Antidepressant monotherapy of major depressive episode in bipolar II disorder: A therapeutic challenge. Psychiatric Annals, 35(12):981-992, 2005.

 

193. Leykin, Y., Amsterdam, J.D., DeRubeis, R.J., Shelton, R.C., Hollon, S.D.: Progressive resistance to SSRI therapy but not to cognitive therapy in the treatment of major depression. Journal of Consulting & Clinical Psychology, 75(2):267-276, 2007. 

 

194. Amsterdam, J.D., Bodkin, J.A.: Selegiline transdermal system and the prevention of relapse of major depressive disorder: a 52-week, double-blind placebo-substitution [A1] parallel-group clinical trial. Journal of Clinical Psychopharmacology, 26:579-586, 2006.

 

195. Amsterdam, J.D.: Monoamine oxidase inhibitor therapy in severe and resistant depression. Psychiatric Annals 36(9):606-617, 2006.

 

196. Amsterdam, J.D., Shults, J., Rutherford, N., Schwartz, S.: Safety and efficacy of s-citalopram in the treatment of co-morbid major depression and diabetes mellitus. Neuropsychobiology, 54:208-214, 2006.

 

197. Newberg, A.B., Amsterdam, J.D., Shults, J.: Dopamine transporter density may be associated with the depressed affect in healthy subjects. Nuclear Medicine Communications, 28(1):3-6, 2007.

 

198. Cusin, C., Perlis, R.H., Amsterdam, J.D., Quitkin, F.M., Reimherr, F.W., Zajecka, J., Beasley, C.M., Rosenbaum, J.F., Fava, M.: Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: Prevalence and implications. Journal of Clinical Psychiatry, 68(1):52-57, 2007.

 

199. Leykin, Y., DeRubeis R.J., Gallop, R., Amsterdam, J.D., Shelton, R.C., Hollon, S.D.: The relation of patients treatment preferences to outcome in a randomized clinical trial. Behavior Therapy, 38(3):209-217, 2007.

 

200. Richmond, T.S., Hollander J.E., Ackerson, T.H., Robinson, K., Gracias, V., Shults, J., Amsterdam, J.D.: Psychiatric disorders in patients presenting to the emergency department for minor injury. Nursing Research, 50(4):275-282, 2007.

 

201. Robinson, D.S., Amsterdam, J.D.: The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability. Journal of Affective Disorders, 105(1-3):15-23, 2008.

 

202. Tang, T.Z., DeRubeis, R.J., Hollon, S.D., Amsterdam, J.D., Shelton, R.: Sudden gains in cognitive therapy for depression and depression relapse/recurrence.  Journal of Consulting and Clinical Psychology, 75(3):404-408, 2007. 

203. Amsterdam, J.D., Newberg, A.B.: A Preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology, 55(3-4):167-170, 2007.

 

204. Amsterdam, J.D., Shults, J., Rutherford, N.: Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32:100-106, 2008.

 

205. Leykin, Y., DeRubeis R.J., Shelton, R.C., Amsterdam, J.D.: Changes in patients beliefs about the causes of their depression following successful treatment. Cognitive Therapy and Research, 31(4):437-449, 2007.

 

206. Fournier, J.C., DeRubeis, R.J., Shelton, R.C., Amsterdam, J.D., Hollon, S.D.: Cognitive therapy versus antidepressant medications in the treatment of depressed patients with and without personality disorder. British Journal of Psychiatry, 192:124-129, 2008.

 

207. Dunner, D.L., Amsterdam, J.D., Shelton, R.C., Loebel, A., Romano, S.J.: Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: A randomized pilot study. Journal of Clinical Psychiatry, 68(7) 1071-1077, 2007.

 

208. Clayton, A.H., Campbell, B.J., Favit, A., Yang, Y., Moonsammy, G., Piontek, C.M., Amsterdam, J.D.: Symptoms of sexual dysfunction in patients treated for major depressive disorder: A comparison between selegiline transdermal system 6 mg/24 hr and placebo using a patient-rated scale. Journal of Clinical Psychiatry, 68(12):1860-1876, 2008.

 

209. Amsterdam, J.D., Shults, J.: Comparison of short-term venlafaxine versus lithium  monotherapy of bipolar II major depressive episode: A randomized open-label study. Journal of Clinical Psychopharmacology, 28(2):171-181, 2008.

 

210. Bhar, S.S., Gelfand, L., Schmid, S.P., Gallop, R., DeRubeis, R., Hollon, S.D., Amsterdam, J.D., Beck, A.T.: Sequence of improvement in depressive symptoms across cognitive therapy and. Journal of Affective Disorders, 110:161-166, 2008.

 

211. Amsterdam, J.D., Wang, C-H., Schwarz, M., Shults, J.: Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: A randomized, parallel group, open-label trial. Journal of Affective Disorders, 112:219-230, 2009.

 

212. Amsterdam, J.D., Williams, D., Michelson, D., Adler, L.A., Dunner, S.L., Nierenberg, A.A., Reimherr, F.W., Schatzberg, A.F.: Tachyphylaxis after repeated antidepressant drug exposures in patients with recurrent major depressive disorder. Neuropsychobiology, 59:227-233, 2009.

 

213. Tohen, M., Vieta, E., Goodwin, G., Sun, B., Amsterdam, J.D., Banov, M., Shekhar, A., Aaronson, S.T., Bardenstein, L., Grecu, J.G., Tochilov, V., Prelipceanu, D., Oliff, H.S.,  Kryzhanovskaya, L., Bowden, C.: Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: A randomized, double-blind study. Journal of Clinical Psychiatry, 2008, 69(11): 1776-89, 2008.

 

214. Richmond, T.S., Amsterdam, J.D., Guo, W., Ackerson, T.H., Gracias, V., Robinson, K., Hollander, J.E.: The effect of post-injury depression on return to pre-injury function:  a prospective cohort study. Psychological Medicine, 2: 1-14, 2009.

 

215. Lundgren, J.D., Amsterdam, J.D., Newberg, A., Allison, K.C., Wintering, N., Stunkard, A.J.:  Differences in serotonin transporter binding affinity in patients with major depressive disorder and night eating syndrome. Eating & Weight Disorders, 14(1): 45-50, 2009.

 

216. Amsterdam, J.D., Shults, J.: Does tachyphylaxis occur after repeated anti-depressant exposure in patients with bipolar II major depressive episode? Journal of Affective Disorders, 112:219-230, 2009.

 

217. Fournier, J.C., DeRubeis, R.J., Shelton, R.C., Hollon, S.D., Amsterdam, J.D., Gallop, B.: Prediction of response in medication and cognitive therapy in the treatment of moderate to severe depression. Journal of Consulting & Clinical Psychology, 77(4):775-787, 2009.

 

218. Shults, J., Sun, W., Tu, X., Amsterdam, J.D., Hilbe, M.J., Ten-Have, T: A comparison of several approaches for choosing between working correlation structures in generalized estimating equation analysis of longitudinal binary data. Statistics in Medicine, 28(18):2338-2355, 2009.

 

219. Amsterdam, J.D., Li, Y., Soeller, I., Rockwell, K., Mao, J.J., Shults, J.: A randomized, double-blind, placebo-controlled, trial of oral Matricaria recutita (Chamomile) extract therapy of generalized anxiety disorder. Journal of Clinical Psychopharmacology, 29(4):378-382, 2009.

 

220. Amsterdam, J.D., Yao, Y., Mao, J.J.,  Soeller, I., Rockwell, K., Shults, J.: Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (Black Cohosh) in women with anxiety disorder due to menopause – lack of efficacy. Journal of Clinical Psychopharmacology, 29(5):478-483, 2009.

 

221. Tang, T.Z., DeRubeis, R.J., Hollon, S.D., Amsterdam, J.D., Shelton, R., Schalet, B.: Personality change during depression treatment: A placebo-controlled trial. Archives of General Psychiatry,  66(12):1322-1330, 2009.

 

222. Reimherr, F.W., Amsterdam, J.D., Dunner, D.L., Adler, L.A., Zhang, S., Williams, D.W., Marchant, B.K., Michelson, D., Nierenberg, A.A., Schatzberg, A.F., Feldman, P.D.: Genetic polymorphisms in the treatment of depression: Speculations from an augmentation study using atomoxetine. Psychiatry Research, 175(1-2):67-73, 2010

 

223. Amsterdam, J.D., Wang, G., Shults, J: Venlafaxine monotherapy of bipolar II major depressive episode in non-responders to prior lithium monotherapy: A cross-over study. Acta Psychiatrica Scandinavica, 121:201-208, 2010.

 

224. Fournier, J.S., DeRubeis, R.J., Hollon, S.D., Dimidjian, S., Amsterdam, J.D., Shelton, R.C.,  Fawcett, J.: Antidepressant drug effects and depression severity: A patient-level meta-analysis. Journal of the American Medical Association, 303(1):47-53, 2010.

 

225. Amsterdam, J.D., Shults, J: Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar type II disorder – A randomized, double-blind, placebo-substitution trial. American Journal of Psychiatry, 167(7):792-800, 2010.

 

226. Amsterdam, J.D., Shults, J: Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode. Low mood conversion rate during initial fluoxetine monotherapy of bipolar type II major depressive episode. Journal of Clinical Psychopharmacology, 30(3):306-311, 2010.

 

227. Mao, J.J., Palmer, C.S., Healy, K., Desai, K., Amsterdam, J.D.: Complementary and alternative medicine use among cancer survivors: a population-based study. Journal of Cancer Survivorship, 5:8-17, 2011.

 

228. Moss, A.S., Monti, D.A., Amsterdam, J.D., Newberg, A.B.: Complementary and alternative medicine therapies in mood disorders. Expert Reviews in Neurotherapeutics 11(7):1049-1056, 2011.

 

229. Strunk, D.R., Stewart, M.O., Hollon, S.D., DeRubeis, R.J., Fawcett, J., Amsterdam, J.D., Shelton, R.C.: A process study of active medication and placebo in the treatment of depression. Psychological Medicine, 40:1379-1387, 2010.

 

230. Webb, C.A., DeRubeis, R.J., Amsterdam, J.D., Shelton, R.C, Hollon, S.D., Dimidjian, S: Two aspects of the therapeutic alliance: Differential relations with depressive symptom change. Journal of Consulting & Clinical Psychology, l 79(3):279-283, 2011.

 

231. Newberg, A.B., Amsterdam, J.D., Wintering, N., Shults, J.: Reduced brain serotonin transporter density in major depressive disorder. Psychiatry Research Neuroimaging, 202:161–167, 2012.

 

232. Amsterdam, J.D., Shults, J., Soeller, I., Mao, J.J., Rockwell, K., Newberg,, A.B.: Chamomile (Matricaria recutita) may have antidepressant activity in anxious depressed humans. Alternative Therapies in Health and Medicine, 18(5):44-49, 2012.

 

233. Amsterdam, J.D., McHenry, L.B.:  The paroxetine 352 bipolar trial: A study in medical ghostwriting.  International Journal of Risk & Safety in Medicine, 24:221–231, 2012.

 

234. Guerra, M., Shults, J., Amsterdam, J.D., Ten Have, T.: The analysis of binary longitudinal data with time-dependent covariates. Statistics in Medicine, Published on-line 13 January 2012.

 

235. Amsterdam, J.D., Newberg, A.B., Soeller, I , Shults, J.: Greater striatal dopamine transporter density may be a biomarker of major depressive episode. Journal of Affective Disorders, 141:425–431, 2012.

 

236. Webb, C.A., DeRubeis, R.J., Dimidjian, S., Hollon, S.D., Amsterdam, J.D., Shelton, R.C.: Predictors of patient cognitive therapy skills and symptom change in two randomized clinical trials: The role of therapist adherence and the therapeutic alliance. Journal of Consulting & Clinical Psychology, 80(3):373–381, 2012.

 

237. Forand, N.R., DeRubeis, R.J. Amsterdam, J.D.: Combination of psychotherapy and medication in the treatment of mental disorders. In: Lambert, M.J. (Ed.) Bergin & Garfield's Handbook of Psychotherapy and Behavior Change, 6th Edition; Hoboken, NJ: Wiley, pp. 735-774, 2013.

 

238. Amsterdam, J.D., Luo, L., Shults, J.: Efficacy and mood conversion rate during long-term fluoxetine versus lithium monotherapy in rapid and non-rapid cycling bipolar type II patients. British Journal of Psychiatry, 202:301-306, 2013.

 

239. Fournier, J.C., DeRubeis, R.J., Shelton, R., Gallop, R., Hollon, D.F., Amsterdam, J.D.:  Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy. Behavior Research and Therapy, 51:392-398, 2013.

 

240. Amsterdam, J.D., Luo, L., Shults, J.: Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression. Journal of Clinical Psychopharmacolog ,33(3):420-424, 2013.

 

241. Amsterdam, J.D., Newberg, A.D., Newman, C.F., Shults, J., Soeller, I., Wintering, N.: Change over time in brain serotonin transporter binding in major depression: Effects of therapy measured with [123I]-ADAM SPECT.  Journal of Neuroimaging, 23(4):469-476, 2013.

 

242. Webb, C.A., DeRubeis, R.J., Hollon, S.D., Dimidjian, S., Amsterdam, J.D., Shelton, R.C. (in press). Convergence and divergence in the delivery of cognitive Therapy in two randomized clinical trial. Behavior Research & Therapy, 51:493-498, 2013.

 

243. Fournier, J.C., DeRubeis, R.J, Amsterdam,J.D., Shelton, R.C., Hollon, S.D.: Gains in employment status following antidepressant medication or cognitive therapy for depression. British Journal of Psychiatry, 206:332-338, 2015 (Published online June 12, 2014)

 

244. Pacchiarotti, I., Bond, D.J., Baldessarini, R.J., Nolen, W.A., Grunze, H., Licht, R.W. Post, R.W., Berk, M., Goodwin, G.M., Sachs, G.S., Tondo L., Findling, R.L., Youngstrom, E.A., Tohen, M., Undurraga, J., González-Pinto, A., Goldberg, J.F., Yildiz, A., Altshuler, L.L., Calabrese, J.R., Mitchell, P.B., Thase, M.E., Koukopoulos, A., Colom, F., Frye, M.A., Malhi, G.S., Fountoulakis, K.N., Vázquez, G., Perlis, R.H., Ketter, T.A., Cassidy, F., Akiskal, H., Azorin, J=M., Valentí, M., Mazzei, D.H., Lafer, B., Kato, T., Mazzarini, L., Martínez-Aran, A., Parker, G., Souery, D., Özerdem, A., McElroy, S.L., Girardi, P., Bauer, M., Yatham, L.N., Zarate, C.A., Nierenberg, A.A., Birmaher, B., Kanba, S., El-Mallakh, R.S., Serretti, A., Rihmer, Z., Young, A.H., Kotzalidis, G.D., MacQueen, G.M., Bowden, C.L., Ghaemi, S.N., Lopez-Jaramillo, C., Rybakowski, J.K., Ha, K., Perugi, G., Kasper, S., Amsterdam, J.D., Hirschfeld, R.M., Kapczinski, F., Vieta, E.: The International Society for Bipolar Disorders (ISBD) Task Force report on antidepressant use in bipolar disorders. American Journal of Psychiatry, 170(11):1249-1262,  2013.

 

245. Richmond, T.S., Guo, W., Ackerson, T., Hollander, J., Gracias, V., Robinson, K., Amsterdam, J.D.: The effect of post-injury depression on quality of life in the year following minor injury: a longitudinal cohort study. Journal of Nursing Scholarship, 46(2): 116–124, 2014.

 

246. Hollon, S.D., DeRubeis, R.J., Fawcett, J., Amsterdam, J.D., Shelton, R.C., Zajecka, J., Young, P.R., Gallop, R.: Cognitive therapy enhances rate of recovery to antidepressant medications for patients with major depressive disorder: A randomized controlled trial. JAMA Psychiatry, 71(10), 1157-1164, 2014.

 

247. Mao, J.J., Li, Q.S., Soeller, I., Xie, S.X., Amsterdam, J.D.: Rhodiola rosea therapy for major depressive disorder: A study protocol for a randomized, double-blind, placebo- controlled trial. Journal of Clinical Trials Published on-line, 4:188, 2014. http://dx.doi.org/10.4172/2167-0870.1000170.

 

248. Mao, J.J., Xie, S.X., Zee, J., Soeller, I., Li, S.Q., Rockwell, K., Amsterdam, J.D.: Rhodiola rose vs. sertraline for major depressive disorder: A randomized placebo-controlled trial.   PhytoMedicine, 22:394-399, 2015.

 

249. Amsterdam, J.D., Rybakowski, J.K.: Pharrmacotherapy of Bipolar Disorder.  In: DeRubeis, R.J., Strunk, D.R. (eds.), The Oxford Handbook of the Mood Disorders. New York. Oxford University Press (in press)

 

250. Amsterdam, J.D., Zajecka, J., Soeller, I., Topel, M., Goldstein, C., DeRubeis, R.J.: Prevention of relapse & recurrence of bipolar depression: A study protocol for a multi-site randomized, double-blind, placebo-substitution trial. Journal of Clinical Trials 4:197, 2014. Published on-line http://omicsgroup.org/journals/prevention-of-relapse-and-recurrence-of-bipolar-type-i-depression-a-study-protocol-for-a-multisite-randomized-2167-0870.1000197.php?aid=35750

 

251. Mao, J.J., Li, Q.S., Soeller, I., Rockwell, K., Xie, S.X., Amsterdam, J.D.: Long-term chamomile therapy of generalized anxiety disorder: A study protocol for a randomized, double-blind, placebo- controlled trial. Journal of Clinical Trials, 4:188, 2014. Published on-line: 2167-0870.1000188, 2015.

 

252. Amsterdam, J.D., Lorenzo-Luaces, L., Soeller, I., ., LQing Li, S., Mao, J.J., DeRubeis, R.J.: Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study. Journal of Affective Disorders, 185;31-37, 2015.

 

253. Amsterdam, J.D., Lorenzo-Luaces, L., Soeller, I., ., LQing Li, S., Mao, J.J., DeRubeis, R.J.: Effectiveness and mood conversion rate of short-term venlafaxine versus lithium monotherapy of bipolar type II major depressive episode – A randomized, double-blind, prospective study. British Journal of Psychiatry, 208:359-365, 2016.

 

254. Jureidini, J.N., Amsterdam, J.D., McHenry, L.B.: The citalopram CIT-MD-18 pediatric depression trial: A deconstruction of medical ghostwriting, data misrepresentation and academic malfeasance. International Journal of Risk & Safety in Medicine, 28:33-43, 2016.

 

255. Lorenzo-Luaces, L., Amsterdam, J.D., Soeller, I., DeRubeis, R.J.: Rapid versus non-rapid bipolar II depression: response to venlafaxine and lithium and hypomanic risk.

Acta Psychiatrica Scandinavica, 133:459-469, 2016.

 

256. Amsterdam, J.D., Panossian, A.g.: Rhodiola rosea L. as a putative botanical antidepressant. Special Issue: Rhodiola. PhytoMedicine, 23(7):770-783, 2016.

 

257. Mao, J.J., Xie, S.X., Keefe, J.R., Li, Q.S., Soeller, I., DeRubeis, RJ.., Amsterdam, J.D.: Long-term chamomile for generalized anxiety disorder: A randomized controlled trial. (in review)

 

258. Keefe, J.R., Amsterdam, J.D., Li, Q.S., Soeller, I., DeRubeis, R.J., Mao, J.J.: Patient expectancies: A specific nonspecific effect in oral therapies. (in review)

 

259. Keefe, J.R., Mao, J.J., Soeller, I., Li, Q.S., Amsterdam, J.D.: Short-term chamomile therapy of generalized anxiety disorder: an open-label study and exploratory analysis (in review)

 

 

 

Jay D. Amsterdam

October 13, 2016